L
Link Cell Therapies
Biotech & Life Sciences · San Carlos, United States · Founded 2022
A True CAR T Cell AND-Gate MoreLess
Link Cell Therapies is a biotechnology company focused on developing next-generation adoptive cell therapies aimed at treating cancer patients. The company operates in the healthcare and life sciences market, primarily serving patients in need of advanced cancer treatments. Link Cell Therapies leverages its proprietary platforms to create precise and effective cell therapies, which are designed to target specific cancer cells with high accuracy. The business model revolves around research and development, clinical trials, and eventual commercialization of its therapeutic products. Revenue is generated through partnerships, grants, and future sales of approved therapies. The company is led by a team of experienced scientists and industry professionals, including Bryan Smith, Ph.D., who leads target discovery efforts. Link Cell Therapies aims to bring innovative and effective treatments to the clinic, improving patient outcomes and advancing the field of oncology.
Keywords: biotechnology, cell therapies, cancer treatment, adoptive cell therapy, oncology, precision medicine, clinical trials, therapeutic platforms, healthcare innovation, life sciences.
Company overview
Link Cell Therapies company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2022
- Headquarters
- San Carlos, United States
- Employees
- 27
- Open positions
- 2
- Dealroom signal
- 55.6
Valuation & funding
Link Cell Therapies funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Dec 2025 | $60M | $240M | Sheatree Capital · Johnson & Johnson Innovation · Wing Venture Capital · Kyowa Kirin | ↗ |
| SPINOUTOther financing | Jan 2022 | $0 | — | Stanford University | — |
Growth signals
Link Cell Therapies website traffic
Latest recorded traffic for Link Cell Therapies is 2.4K monthly website visits, down 4% over the last three months. Link Cell Therapies's team grew 237.5% over the past year.
Hiring
Open positions at Link Cell Therapies
Current openings linked to this company in Dealroom.
Comparisons
Link Cell Therapies compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Link Cell Therapies's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Link Cell Therapies's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Link Cell Therapies has talent and traffic
team presence
In the news
Latest news about Link Cell Therapies
Recent press, funding announcements, and product moves mentioning Link Cell Therapies — open to read from the original sources.
Market sentiment
What the market is saying about Link Cell Therapies
An AI-synthesized read of the highest-engagement posts about Link Cell Therapies on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Link Cell Therapies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.